Iron deficiency anaemia is a highly prevalent public health problem globally, affecting over 1.5 billion people. It occurs due to inadequate iron intake, losses through bleeding, or problems with iron absorption and metabolism. Women are particularly vulnerable as iron requirements increase during menstruation and pregnancy. Diagnosis involves blood tests showing microcytic, hypochromic red blood cells and low iron stores. Treatment focuses on oral or parental iron supplementation to correct the anaemia and replenish iron levels, while prevention emphasizes nutrition education and food fortification.
Iron deficiency anemia- a review of diagnosis and managementUnggul Dedi
This document reviews iron-deficiency anemia (IDA), including its diagnosis and management. It begins by explaining that anemia is very common globally and IDA is the most frequent type, often caused by insufficient iron intake, absorption or blood loss. The review then describes iron metabolism and the process of erythropoiesis. It discusses evaluating patients for IDA through medical history, examination, and lab tests like ferritin and transferrin levels. For diagnosed IDA, the review recommends determining the underlying cause, such as gastrointestinal bleeding, and treating the specific condition. It emphasizes the importance of thorough diagnosis and management to address the health effects of IDA.
Iron is an essential mineral that is distributed throughout the body and is important for oxygen transport and cellular metabolism. Iron deficiency develops when requirements exceed supply and leads to iron deficient erythropoiesis and eventually iron deficiency anemia. It is one of the most common nutritional deficiencies worldwide, affecting toddlers, adolescent girls, pregnant women, and some minority groups. Treatment involves oral or parenteral iron supplementation depending on severity, with the goal of replenishing iron stores and repairing hemoglobin deficits.
The document provides an overview of iron metabolism in the human body. It discusses dietary iron sources and requirements, absorption of iron in the small intestine, transport of iron in the blood via transferrin, storage of iron in the liver, spleen and bone marrow as ferritin and hemosiderin, the role of iron in hemoglobin and other proteins, excretion of iron primarily in feces, and laboratory tests to diagnose iron deficiency or overload. Conditions related to iron such as iron deficiency anemia and hemochromatosis are also summarized.
Iron deficiency anemia develops when iron stores are too low to support normal red blood cell production. It can be caused by inadequate dietary iron, impaired iron absorption, bleeding, or loss of body iron. Diagnosis involves a complete blood count showing microcytic, hypochromic anemia and low serum iron and ferritin levels. Treatment primarily involves oral iron supplementation, while parenteral iron or blood transfusions are reserved for more severe cases. The underlying cause also needs to be addressed to prevent recurrence.
Iron is an essential trace element in the human body, with the total body content being 3-5 grams. It exists in both heme and non-heme forms, with heme iron making up 75% of total iron and being found in hemoglobin, myoglobin, and enzymes. Iron is absorbed in the duodenum in its ferrous form and transported bound to transferrin in plasma. It is either stored bound to ferritin or transported to tissues where it participates in oxygen transport and electron transport. Iron deficiency anemia is the most common nutritional deficiency globally, while iron overload can result in hemosiderosis or hemochromatosis.
Iron deficiency anemia is the most common type of anemia seen in clinical practice. It is characterized by a decrease in hemoglobin and oxygen-carrying capacity due to low iron levels. Oral iron supplements are usually the first line treatment, with ferrous sulfate being a commonly used and inexpensive option. Parenteral iron is considered when oral iron is not tolerated or absorbed. The document provides details on causes of iron deficiency anemia, distribution and absorption of iron in the body, classification of anemias, oral and parenteral iron preparations and their administration, and indications and adverse effects of iron therapy.
Iron deficiency anemia- a review of diagnosis and managementUnggul Dedi
This document reviews iron-deficiency anemia (IDA), including its diagnosis and management. It begins by explaining that anemia is very common globally and IDA is the most frequent type, often caused by insufficient iron intake, absorption or blood loss. The review then describes iron metabolism and the process of erythropoiesis. It discusses evaluating patients for IDA through medical history, examination, and lab tests like ferritin and transferrin levels. For diagnosed IDA, the review recommends determining the underlying cause, such as gastrointestinal bleeding, and treating the specific condition. It emphasizes the importance of thorough diagnosis and management to address the health effects of IDA.
Iron is an essential mineral that is distributed throughout the body and is important for oxygen transport and cellular metabolism. Iron deficiency develops when requirements exceed supply and leads to iron deficient erythropoiesis and eventually iron deficiency anemia. It is one of the most common nutritional deficiencies worldwide, affecting toddlers, adolescent girls, pregnant women, and some minority groups. Treatment involves oral or parenteral iron supplementation depending on severity, with the goal of replenishing iron stores and repairing hemoglobin deficits.
The document provides an overview of iron metabolism in the human body. It discusses dietary iron sources and requirements, absorption of iron in the small intestine, transport of iron in the blood via transferrin, storage of iron in the liver, spleen and bone marrow as ferritin and hemosiderin, the role of iron in hemoglobin and other proteins, excretion of iron primarily in feces, and laboratory tests to diagnose iron deficiency or overload. Conditions related to iron such as iron deficiency anemia and hemochromatosis are also summarized.
Iron deficiency anemia develops when iron stores are too low to support normal red blood cell production. It can be caused by inadequate dietary iron, impaired iron absorption, bleeding, or loss of body iron. Diagnosis involves a complete blood count showing microcytic, hypochromic anemia and low serum iron and ferritin levels. Treatment primarily involves oral iron supplementation, while parenteral iron or blood transfusions are reserved for more severe cases. The underlying cause also needs to be addressed to prevent recurrence.
Iron is an essential trace element in the human body, with the total body content being 3-5 grams. It exists in both heme and non-heme forms, with heme iron making up 75% of total iron and being found in hemoglobin, myoglobin, and enzymes. Iron is absorbed in the duodenum in its ferrous form and transported bound to transferrin in plasma. It is either stored bound to ferritin or transported to tissues where it participates in oxygen transport and electron transport. Iron deficiency anemia is the most common nutritional deficiency globally, while iron overload can result in hemosiderosis or hemochromatosis.
Iron deficiency anemia is the most common type of anemia seen in clinical practice. It is characterized by a decrease in hemoglobin and oxygen-carrying capacity due to low iron levels. Oral iron supplements are usually the first line treatment, with ferrous sulfate being a commonly used and inexpensive option. Parenteral iron is considered when oral iron is not tolerated or absorbed. The document provides details on causes of iron deficiency anemia, distribution and absorption of iron in the body, classification of anemias, oral and parenteral iron preparations and their administration, and indications and adverse effects of iron therapy.
Iron deficiency anemia is one of the most common medical problems and the most common cause of anemia. It occurs when iron levels and stores in the body are depleted. Symptoms include fatigue, glossitis, angular stomatitis, and nail changes. Laboratory tests show low hemoglobin, MCV, MCHC, serum iron, and ferritin levels. Treatment involves oral or parental iron replacement therapy to replenish iron stores along with treating any underlying causes of blood loss. Parenteral iron is reserved for cases of malabsorption or noncompliance with oral therapy.
Irion defitient and megaloblastic anemiasJasmine John
This document summarizes iron deficiency anemia and megaloblastic anemia. It discusses the causes, symptoms, laboratory findings, treatment, and prognosis of these conditions. Iron deficiency is the most common cause of anemia worldwide and results from inadequate iron intake or absorption. Megaloblastic anemia is caused by vitamin B12 or folate deficiencies and results in abnormal DNA synthesis and large, immature red blood cells. Treatment involves oral or intravenous iron supplementation for iron deficiency and vitamin B12/folate supplementation for megaloblastic anemia.
This document discusses the management of anemia in pregnancy. It begins with an introduction to hematopoiesis and iron metabolism. It then reviews the normal hematologic changes that occur during pregnancy, including increases in plasma volume and erythropoietin levels. The document discusses iron requirements and metabolism in pregnancy. It identifies the most common causes of anemia in pregnancy as physiological anemia and iron deficiency anemia. The document outlines various ways of classifying anemias, including by mechanism, cell morphology, and heritability. It provides details on diagnosing and distinguishing between physiological anemia and iron deficiency anemia.
This document discusses iron refractory iron deficiency anemia (IRIDA). It defines key terms like anemia and iron deficiency. It describes normal iron metabolism and the role of transport proteins like DMT1 and ferroportin in intestinal iron absorption. Hepcidin regulates iron transport by binding to ferroportin and inducing its degradation. Mutations in ferroportin can cause iron overload by preventing its binding to hepcidin. The document also discusses rare conditions like atransferrinemia caused by near absence of plasma transferrin.
Anemia is a common complication of chronic kidney disease (CKD) that worsens as kidney function declines. It results from inadequate production of erythropoietin and impaired iron absorption and transport. Anemia in CKD is associated with increased morbidity and mortality. Laboratory tests are used to diagnose and monitor anemia, including hemoglobin, ferritin, transferrin saturation, and others. Treatment involves iron supplementation through oral or intravenous routes, as well as erythropoiesis-stimulating agents, with the goal of reducing transfusions and symptoms while improving quality of life.
Anaemia is defined as a reduction in haemoglobin, red blood cells or haematocrit below normal levels. Iron-deficiency anaemia (IDA) affects around 2 billion people worldwide. IDA is prevalent in India, affecting 20% of adult males, 40% of non-pregnant females and children, and 80% of pregnant females. IDA is classified based on its underlying cause such as reduced red blood cell production or increased destruction. Oral iron therapy is usually the first line treatment, while blood transfusions or intravenous iron may be used for more severe cases or those who cannot tolerate oral iron. The diagnosis of IDA relies on a low MCV, MCH and iron studies showing low ferritin and transferrin saturation
Approach to a case of iron defciency anaemiaSachin Adukia
- Anaemia is defined as a reduction in haemoglobin, red blood cell count or haematocrit below normal levels. Iron-deficiency anaemia affects around 2 billion people worldwide including 20-40% of people in India.
- Iron-deficiency anaemia is classified based on the underlying cause such as reduced red blood cell production, increased red blood cell destruction, or loss of red blood cells.
- Diagnosis involves examination of symptoms, signs, and laboratory tests including a blood smear, iron studies, and bone marrow examination. Treatment involves oral or intravenous iron supplementation depending on the severity of the deficiency.
This document discusses iron absorption and iron deficiency anemia. It states that iron absorption primarily occurs in the duodenum and jejunum, and is regulated by both dietary intake and iron stores. Iron deficiency is the most common cause of anemia worldwide, especially impacting women and children. The key signs of iron deficiency anemia are a decreased hemoglobin level and red blood cell size.
Anemia is a condition characterized by low red blood cell count or hemoglobin levels. It can be caused by inadequate red blood cell production, increased destruction, or blood loss. Common symptoms include fatigue, pallor, and shortness of breath. Iron deficiency anemia is the most common type and results from inadequate iron intake or absorption. It can cause microcytic hypochromic anemia. Vitamin B12 deficiency can cause megaloblastic anemia due to its role in DNA synthesis. It is caused by low intake, malabsorption, or poor utilization and signs include macrocytosis, neurological symptoms, and smooth muscle problems. Diagnosis involves blood tests and treatment depends on the underlying cause.
This document discusses haematinics, which are substances required for blood formation used to treat anaemias. It describes different types of anaemias caused by blood loss, impaired cell formation due to deficiencies in iron, vitamin B12, or folic acid, or increased destruction of red blood cells. It provides details on iron including absorption, transport, storage, requirements, sources, and preparations for both oral and parenteral administration. It also discusses acute iron poisoning treatment and mentions that vitamin B12 and folic acid deficiencies can result in megaloblastic anaemia.
This document summarizes iron metabolism. It discusses daily iron requirements, absorption and transport of iron, iron storage, and regulation of iron levels. It also covers iron deficiency anemia and iron overload disorders like hemochromatosis. Iron is absorbed in the duodenum and transported bound to transferrin. It is stored primarily in the liver as ferritin or hemosiderin. Iron levels are regulated by the liver peptide hepcidin which controls intestinal iron absorption and macrophage iron recycling by degrading the iron exporter ferroportin.
This document discusses iron and iron deficiency. It provides information on:
1. Iron is essential for hemoglobin formation and is involved in many enzyme systems. Iron deficiency can cause microcytic hypochromic anemia.
2. Causes of iron deficiency include blood loss, inadequate intake, and malabsorption. Good dietary sources include meat, fish, and plant sources like spinach.
3. Oral iron is usually sufficient to treat iron deficiency anemia, though parenteral iron may be needed in cases of malabsorption or intolerance. Different oral and parenteral iron preparations are available.
Rolla Abu-Arja, clinical director of pediatric bone marrow transplant in Nationwide Children's Hospital (Columbus, OH) discusses iron overload in hematopoetic cell transplantation.
Iron deficiency anemia is the most common form of anemia globally. It is caused by low iron intake, absorption issues, increased demands, or blood loss. The document discusses iron metabolism, the stages and clinical features of iron deficiency anemia, and laboratory tests to diagnose it. Key tests include low serum iron, ferritin, and saturation with transferrin, along with microcytic indices on CBC. Bone marrow examination may show iron deficiency. Treatment involves iron supplementation.
This document describes several methods used to assess iron status in the body. It discusses how iron is incorporated into hemoglobin and transported by transferrin. Key methods mentioned include measuring hemoglobin concentration, red blood cell indices, serum iron, total iron binding capacity, transferrin saturation, serum transferrin receptor, red cell zinc proporphyrin, red cell ferritin, hypochromic red cells, serum ferritin, and tissue biopsy iron staining of bone marrow. Each method is outlined with normal reference ranges, diagnostic uses, and potential confounding factors.
Iron chelators in treatment of iron overload syndromesDR RML DELHI
This document reviews different iron chelators used to treat iron overload syndromes. It discusses the main iron chelators - deferoxamine, deferiprone, and deferasirox. Each chelator has advantages and disadvantages in terms of target diseases, levels of iron deposition, and patient symptoms, making the best choice complex. Proper evaluation of iron overload is important for monitoring chelation therapy effectiveness through measures like serum ferritin, liver biopsy, MRI. Chelation aims to prevent excess iron accumulation and related organ dysfunction through safely removing iron from the body.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic use including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev KumarDr. Sookun Rajeev Kumar
1. Iron deficiency anemia is caused by inadequate iron intake or absorption leading to decreased hemoglobin and microcytic red blood cells. Symptoms include weakness, fatigue, and pallor.
2. Diagnosis involves blood tests showing low iron, ferritin and saturation and high TIBC. Peripheral smear shows microcytic hypochromic anemia.
3. Treatment is oral iron supplementation though intravenous may be needed in severe cases. Regular intake and monitoring is important to fully replenish iron stores.
DNA replication is the process where a cell makes an identical copy of its DNA before cell division. It involves unwinding the DNA double helix at the replication fork and using each old strand as a template to synthesize new partner strands. The leading strand is synthesized continuously from 5' to 3' while the lagging strand is synthesized discontinuously in short Okazaki fragments from 5' to 3' that are later joined. DNA polymerase adds nucleotides to the growing strand based on base pairing rules while other proteins such as helicase, primase, ligase and clamps aid in the process. Eukaryotes have multiple DNA polymerases and thousands of replication origins compared to prokaryotes. DNA repair mechanisms fix errors made
The document discusses endocrine physiology and the endocrine system. It describes how hormones regulate target cells and organs through various communication systems, including endocrine, neuroendocrine, paracrine and autocrine signaling. It outlines the major endocrine glands and hormones, including how hormones are classified, transported, and their levels controlled through feedback mechanisms. The role of receptors and intracellular signaling pathways used by peptides and catecholamines to elicit cellular responses is also summarized.
More Related Content
Similar to IRON DEFICIENCY ANAEMIA MBBSBDS IV.pptx
Iron deficiency anemia is one of the most common medical problems and the most common cause of anemia. It occurs when iron levels and stores in the body are depleted. Symptoms include fatigue, glossitis, angular stomatitis, and nail changes. Laboratory tests show low hemoglobin, MCV, MCHC, serum iron, and ferritin levels. Treatment involves oral or parental iron replacement therapy to replenish iron stores along with treating any underlying causes of blood loss. Parenteral iron is reserved for cases of malabsorption or noncompliance with oral therapy.
Irion defitient and megaloblastic anemiasJasmine John
This document summarizes iron deficiency anemia and megaloblastic anemia. It discusses the causes, symptoms, laboratory findings, treatment, and prognosis of these conditions. Iron deficiency is the most common cause of anemia worldwide and results from inadequate iron intake or absorption. Megaloblastic anemia is caused by vitamin B12 or folate deficiencies and results in abnormal DNA synthesis and large, immature red blood cells. Treatment involves oral or intravenous iron supplementation for iron deficiency and vitamin B12/folate supplementation for megaloblastic anemia.
This document discusses the management of anemia in pregnancy. It begins with an introduction to hematopoiesis and iron metabolism. It then reviews the normal hematologic changes that occur during pregnancy, including increases in plasma volume and erythropoietin levels. The document discusses iron requirements and metabolism in pregnancy. It identifies the most common causes of anemia in pregnancy as physiological anemia and iron deficiency anemia. The document outlines various ways of classifying anemias, including by mechanism, cell morphology, and heritability. It provides details on diagnosing and distinguishing between physiological anemia and iron deficiency anemia.
This document discusses iron refractory iron deficiency anemia (IRIDA). It defines key terms like anemia and iron deficiency. It describes normal iron metabolism and the role of transport proteins like DMT1 and ferroportin in intestinal iron absorption. Hepcidin regulates iron transport by binding to ferroportin and inducing its degradation. Mutations in ferroportin can cause iron overload by preventing its binding to hepcidin. The document also discusses rare conditions like atransferrinemia caused by near absence of plasma transferrin.
Anemia is a common complication of chronic kidney disease (CKD) that worsens as kidney function declines. It results from inadequate production of erythropoietin and impaired iron absorption and transport. Anemia in CKD is associated with increased morbidity and mortality. Laboratory tests are used to diagnose and monitor anemia, including hemoglobin, ferritin, transferrin saturation, and others. Treatment involves iron supplementation through oral or intravenous routes, as well as erythropoiesis-stimulating agents, with the goal of reducing transfusions and symptoms while improving quality of life.
Anaemia is defined as a reduction in haemoglobin, red blood cells or haematocrit below normal levels. Iron-deficiency anaemia (IDA) affects around 2 billion people worldwide. IDA is prevalent in India, affecting 20% of adult males, 40% of non-pregnant females and children, and 80% of pregnant females. IDA is classified based on its underlying cause such as reduced red blood cell production or increased destruction. Oral iron therapy is usually the first line treatment, while blood transfusions or intravenous iron may be used for more severe cases or those who cannot tolerate oral iron. The diagnosis of IDA relies on a low MCV, MCH and iron studies showing low ferritin and transferrin saturation
Approach to a case of iron defciency anaemiaSachin Adukia
- Anaemia is defined as a reduction in haemoglobin, red blood cell count or haematocrit below normal levels. Iron-deficiency anaemia affects around 2 billion people worldwide including 20-40% of people in India.
- Iron-deficiency anaemia is classified based on the underlying cause such as reduced red blood cell production, increased red blood cell destruction, or loss of red blood cells.
- Diagnosis involves examination of symptoms, signs, and laboratory tests including a blood smear, iron studies, and bone marrow examination. Treatment involves oral or intravenous iron supplementation depending on the severity of the deficiency.
This document discusses iron absorption and iron deficiency anemia. It states that iron absorption primarily occurs in the duodenum and jejunum, and is regulated by both dietary intake and iron stores. Iron deficiency is the most common cause of anemia worldwide, especially impacting women and children. The key signs of iron deficiency anemia are a decreased hemoglobin level and red blood cell size.
Anemia is a condition characterized by low red blood cell count or hemoglobin levels. It can be caused by inadequate red blood cell production, increased destruction, or blood loss. Common symptoms include fatigue, pallor, and shortness of breath. Iron deficiency anemia is the most common type and results from inadequate iron intake or absorption. It can cause microcytic hypochromic anemia. Vitamin B12 deficiency can cause megaloblastic anemia due to its role in DNA synthesis. It is caused by low intake, malabsorption, or poor utilization and signs include macrocytosis, neurological symptoms, and smooth muscle problems. Diagnosis involves blood tests and treatment depends on the underlying cause.
This document discusses haematinics, which are substances required for blood formation used to treat anaemias. It describes different types of anaemias caused by blood loss, impaired cell formation due to deficiencies in iron, vitamin B12, or folic acid, or increased destruction of red blood cells. It provides details on iron including absorption, transport, storage, requirements, sources, and preparations for both oral and parenteral administration. It also discusses acute iron poisoning treatment and mentions that vitamin B12 and folic acid deficiencies can result in megaloblastic anaemia.
This document summarizes iron metabolism. It discusses daily iron requirements, absorption and transport of iron, iron storage, and regulation of iron levels. It also covers iron deficiency anemia and iron overload disorders like hemochromatosis. Iron is absorbed in the duodenum and transported bound to transferrin. It is stored primarily in the liver as ferritin or hemosiderin. Iron levels are regulated by the liver peptide hepcidin which controls intestinal iron absorption and macrophage iron recycling by degrading the iron exporter ferroportin.
This document discusses iron and iron deficiency. It provides information on:
1. Iron is essential for hemoglobin formation and is involved in many enzyme systems. Iron deficiency can cause microcytic hypochromic anemia.
2. Causes of iron deficiency include blood loss, inadequate intake, and malabsorption. Good dietary sources include meat, fish, and plant sources like spinach.
3. Oral iron is usually sufficient to treat iron deficiency anemia, though parenteral iron may be needed in cases of malabsorption or intolerance. Different oral and parenteral iron preparations are available.
Rolla Abu-Arja, clinical director of pediatric bone marrow transplant in Nationwide Children's Hospital (Columbus, OH) discusses iron overload in hematopoetic cell transplantation.
Iron deficiency anemia is the most common form of anemia globally. It is caused by low iron intake, absorption issues, increased demands, or blood loss. The document discusses iron metabolism, the stages and clinical features of iron deficiency anemia, and laboratory tests to diagnose it. Key tests include low serum iron, ferritin, and saturation with transferrin, along with microcytic indices on CBC. Bone marrow examination may show iron deficiency. Treatment involves iron supplementation.
This document describes several methods used to assess iron status in the body. It discusses how iron is incorporated into hemoglobin and transported by transferrin. Key methods mentioned include measuring hemoglobin concentration, red blood cell indices, serum iron, total iron binding capacity, transferrin saturation, serum transferrin receptor, red cell zinc proporphyrin, red cell ferritin, hypochromic red cells, serum ferritin, and tissue biopsy iron staining of bone marrow. Each method is outlined with normal reference ranges, diagnostic uses, and potential confounding factors.
Iron chelators in treatment of iron overload syndromesDR RML DELHI
This document reviews different iron chelators used to treat iron overload syndromes. It discusses the main iron chelators - deferoxamine, deferiprone, and deferasirox. Each chelator has advantages and disadvantages in terms of target diseases, levels of iron deposition, and patient symptoms, making the best choice complex. Proper evaluation of iron overload is important for monitoring chelation therapy effectiveness through measures like serum ferritin, liver biopsy, MRI. Chelation aims to prevent excess iron accumulation and related organ dysfunction through safely removing iron from the body.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic use including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev KumarDr. Sookun Rajeev Kumar
1. Iron deficiency anemia is caused by inadequate iron intake or absorption leading to decreased hemoglobin and microcytic red blood cells. Symptoms include weakness, fatigue, and pallor.
2. Diagnosis involves blood tests showing low iron, ferritin and saturation and high TIBC. Peripheral smear shows microcytic hypochromic anemia.
3. Treatment is oral iron supplementation though intravenous may be needed in severe cases. Regular intake and monitoring is important to fully replenish iron stores.
Similar to IRON DEFICIENCY ANAEMIA MBBSBDS IV.pptx (20)
DNA replication is the process where a cell makes an identical copy of its DNA before cell division. It involves unwinding the DNA double helix at the replication fork and using each old strand as a template to synthesize new partner strands. The leading strand is synthesized continuously from 5' to 3' while the lagging strand is synthesized discontinuously in short Okazaki fragments from 5' to 3' that are later joined. DNA polymerase adds nucleotides to the growing strand based on base pairing rules while other proteins such as helicase, primase, ligase and clamps aid in the process. Eukaryotes have multiple DNA polymerases and thousands of replication origins compared to prokaryotes. DNA repair mechanisms fix errors made
The document discusses endocrine physiology and the endocrine system. It describes how hormones regulate target cells and organs through various communication systems, including endocrine, neuroendocrine, paracrine and autocrine signaling. It outlines the major endocrine glands and hormones, including how hormones are classified, transported, and their levels controlled through feedback mechanisms. The role of receptors and intracellular signaling pathways used by peptides and catecholamines to elicit cellular responses is also summarized.
This document discusses neonatal jaundice, including its definition, etiology, bilirubin production and metabolism, types of hyperbilirubinemia, causes, clinical features, kernicterus, and treatment options. Neonatal jaundice is caused by increased bilirubin levels and results in a yellowish skin and eye discoloration. Bilirubin is produced from the breakdown of hemoglobin. Treatment depends on the type and severity of hyperbilirubinemia, and may include phototherapy, exchange blood transfusions, or medications to increase bilirubin clearance from the liver.
Introductory Neurotransmitters New 23 - Copy.pptxYakubuAdamu10
This document provides an overview of neurobiochemistry, including the structure and chemical composition of nerve cells and the general metabolism of the brain. It discusses the structure of neurons and how they transmit signals. The major components of nervous tissue are lipids, proteins, carbohydrates, nucleic acids and minerals. Glucose is the primary fuel for the brain, though ketone bodies can be used alternatively. Amino acids and ammonia are also metabolized in the brain. The document outlines these metabolic pathways and explains how the brain regulates levels of substances like ammonia.
BCH-ANA XENOBIOTICS DETOXIFICATION POWER POINT LECTURE.pptxYakubuAdamu10
The document discusses the detoxification mechanism in the body. It begins by defining xenobiotics as foreign compounds the body is exposed to, such as drugs, pollutants, and certain waste compounds. Detoxification involves converting these compounds to less toxic and more easily excretable forms through two phases. Phase 1 involves reactions like oxidation, reduction and hydrolysis. Phase 2 involves conjugating the compounds with substances like glucuronic acid, glutathione, sulfate and glycine to make them more hydrophilic. The liver plays a key role in detoxification through the cytochrome P450 enzyme system, which catalyzes many oxidation reactions.
DNA replication is the process where a cell makes an identical copy of its DNA before cell division. It occurs in S phase of the cell cycle. The double helix unwinds and each strand serves as a template to make a new partner strand. DNA polymerase adds nucleotides to the growing strand in the 5’ to 3’ direction. The leading strand is continuously synthesized while the lagging strand is synthesized in fragments. DNA replication ensures each new cell has an exact copy of the DNA sequence.
The genetic code consists of triplets of nucleotide bases called codons that specify which amino acid will be incorporated into a growing polypeptide chain. There are 64 possible codons composed of combinations of the bases A, G, C, and U, which encode the 20 standard amino acids. Some amino acids have multiple codons due to degeneracy in the code. Point mutations in DNA that alter codons can cause silent, missense, or nonsense mutations depending on whether the codon specifies the same, a different, or a stop amino acid. Frameshift mutations disrupt the reading frame and result in a completely different amino acid sequence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
1. Iron deficiency
anaemia
DR ABBA AISHA MOHAMMED
DEPARTMENT OF HAEMATOLOGY
FACULTY OF BASIC CLINICAL SCIENCES
UNIVERSITY OF MAIDUGURI
7/10/2023
1
2. OBJECTIVES
To define iron deficiency anaemia
To understand iron metabolism
To identify the causes & consequences of IDA
To be able to effectively diagnose and manage IDA
7/10/2023
2
3. OUTLINE
Introduction
Iron metabolism
Clinical features/ consequence of iron
deficiency/Stages of iron deficiency
Laboratory diagnosis
Treatment
Prevention
7/10/2023
3
4. INTRODUCTION
Iron deficiency is the decrease in total iron
content of the body
Iron deficiency anaemia occurs when iron
deficiency is severe enough to decrease/
halt erythropoiesis and cause development
of anaemia
IDA diminishes capability of individuals to
work and affects growth and learning
7/10/2023
4
5. CONT’D
Deficiency of iron is the most common cause of anaemia
globally
Affects >1.5 billion people worldwide
Occurs most frequently in under-developed countries
It is the most important differential diagnosis of”
microcytic hypochromic “anaemia (morphologic
classification)
7/10/2023
5
6. IRON METABOLOSM
o Iron requirements vary daily as it
compensates for losses from the
body and growth requirements
o Pregnant women, menstruating
females and adolescents have the
highest demands
7/10/2023
6
7. DAILY REQUIREMENTS OF IRON
Infants up to 4 months- 0.5mg
Infants 5-12 months and children-
1mg
Menstruating women-3mg
Pregnancy- 3-4mg
Adult male and postmenopausal
women-1mg
7/10/2023
7
8. SOURCES OF IRON
Animal sources- red meat, dairy
products(milk is a poor source
of iron)
Plant sources- fruits, cereals,
legumes,vegetables
7/10/2023
8
11. IRON METABOLISM
Dietary iron is present in foods in
the ferric form (ferric hydroxides and
ferric protein)
The proportion of iron absorbed
differs from one food to another;
meat is the richest source of iron
Depending on the type of food
taken, iron is absorbed partly as
haeme and partly as inorganic iron
7/10/2023
11
13. ABSORPTION OF IRON
Haeme iron is absorbed directly through
the duodenum to the portal circulation
While inorganic iron is first converted to
ferrous form (ferrireductase) and
internalized with the aid of DMT1
7/10/2023
13
14. CONT’D
Inside the cell it is either stored as ferritin
or transported to the plasma
Exit of iron from the duodenal enterocyte
into the portal plasma is controlled by
ferroportin
Ferrioxidase converts ferrous to ferric iron
to enable it bind to transferrin
7/10/2023
14
16. TRANSPORT OF IRON
Transferrin; a glycoprotein produce by the liver
delivers iron to tissues that have transferrin
receptors e.g marrow erythroblasts, for
incorporation into haemoglobin and other cells of
the body. Transferrin is then re-utilized
Iron in the erythroblast cytoplasm moves to the
mitochondria for haeme synthesis
Some iron is stored in the lysosome as ferritin
(sideroblasts)
7/10/2023
16
17. STORAGE OF IRON
Ferritin - water soluble consisting of a
protein shell and iron core, contains
numerous ferric oxyhydroxide molecules
and is readily mobilised for haemoglobin
synthesis when required
7/10/2023
17
18. CONT’D
Haemosiderin –represents aggregation of
ferritin from which most of the protein has
been removed. It is stored in the RES, it is
water insoluble and less readily available
for haemoglobin synthesis
7/10/2023
18
19. REGULATION OF IRON : HEPCIDIN
A 25 amino acid polypeptide hormone
produced by the liver
known to be the key regulator of iron
metabolism
It causes internalisation and degradation
of ferroportin; the only iron exporter at the
basolateral end of the enterocyte
7/10/2023
19
20. CONT’D
There by inhibiting iron absorption from
the GIT and release by the macrophages
Hepcidin levels fall in iron deficiency ,
hypoxia and erythropoietic drive
Plasma transferrin saturation and
inflammation stimulate hepcidin synthesis
7/10/2023
20
22. STAGES OF IRON DEFICIENCY
Iron store depletion- absent iron stores
Iron deficient erythropoiesis (latent iron
deficiency)- absent iron stores with
reduction of plasma concentration of
iron
Iron deficiency anaemia- the two above
with blood film features of iron
deficiency
7/10/2023
22
27. Clinical features
GENERAL FEATURES OF ANAEMIA-
Weakness, easy fatiguability, breathlessness
on exertion, tachycardia and a systolic heart
murmur e.t.c
7/10/2023
27
28. CONT’D
FEATURES RELATED TO IRON DEFICIENCY-
pica;abnormal intense desire to eat strange
substances such as clay,,paint cardboard etc.
atrophic glossitis, dysphagia,angular
stomatitis and koilonychia
Iron def. anaemia+ glossitis+dysphagia=
Patterson Kelly (or plummer-vinson)
syndrome
7/10/2023
28
29. Cont’d
FEATURES DUE TO UNDERLYING CAUSE-
bleeding from GIT,menorrhagia,alteration in
bowel habit, hemoptysis e.t.c
7/10/2023
29
32. DIAGNOSIS
1.PERIPHERAL BLOOD FILM
RED cells show Anisopoikilocytosis with
microcytic hypochromic cells, pencil cells,
occasional target cells
PLATELETS; thrombocytosis
LEUCOCYTES normal or increased (with
infection or infestation)
7/10/2023
32
33. CONT’D
NOTE: A dimorphic picture is seen if the
patient has received transfusion, has
coexisting folate or vit B12 deficiency or
received recent iron therapy
7/10/2023
33
35. CONT’D
5.TIBC/ Serum transferrin receptor ↑
6.Free red cell portopophyrin ↑
7.Serum hepcidin ↓
8.Bone marrow examination (GOLD
STARNDARD ) stained with Prussian blue
(perl’s reaction) will show absent iron in
macrophages, but is not necessary except in
complicated cases
7/10/2023
35
39. TREATMENT
1. Identify the underlying cause and treat
appropriately
2. Iron replacement therapy
Aim- to correct anaemia and replenish the
stores
7/10/2023
39
40. CONT’D
Two forms of iron replacement therapy
are in use
1. The oral formulations
2. The parenteral formulations
7/10/2023
40
41. CONT’D
1.Ferrous sulphate (BEST preparation) ,
contains 67mg of elemental iron in 200mg
tablet. Administration is 6-8hrly on an empty
stomach. Side effects include nausea,
abdominal discomfort and diarrhea or
constipation
2. Ferrous gluconate , contaims 37mg iron in
300mg tablet(does not deliver required iron
content) ,has less side effect
3. Ferrous fumarate
7/10/2023
41
42. CONT’D
NOTE: Therapy is given for at least 6 months
to correct anaemia and replenish the stores
Failure to respond to oral iron therapy-
On going haemorrhage
Non-compliance
Wrong diagnosis
Mixed deficiencies
Malabsorption
7/10/2023
42
43. CONT’D
PARENTERAL IRON THERAPY –
1. Ferric-hydroxide sucrose
2. Iron dextran
3. Ferric carboxymaltose
These are calculated according to weight and
degree of anaemia
7/10/2023
43
44. CONT’D
1 and 2 are commonly used in our
centre
1 is give as an slow IV injection or
infusion
2 is given as deep IM injection spread
over a week
7/10/2023
44
45. CONT’D
Indicated only – GI bleeding, severe
menorrhagia, chronic haemodialysis,
erythropoeitin therapy and when oral iron
is ineffective
Side effects of parenteral iron therapy
includes- hypersensitivity reactions, muscle
staining,
7/10/2023
45
46. CONT’D
NOTE: there is no superiority in
haematological response of parenteral iron
over oral iron therapy
7/10/2023
46
47. PREVENTION
Iron supplementation
Food fortification
Dietary modification
Control of viral. Bacterial and
parasitic infections
7/10/2023
47
48. SUMMARY
Iron deficiency anaemia is a significant
public health problem globally with varied
aetiology ranging from loss of iron via
blood loss to inadequate intake and
problems of metabolism
7/10/2023
48
49. CONT’D
Women tend to have substantially lower iron
stores than men, thus are more vulnerable to
iron deficiency when iron intake is lowered or
need increases
Diagnosis is made using PBF ,red cell indices in
addition to evaluation of iron stores
7/10/2023
49
50. CONT’D
Treatment is aimed at correcting anaemia
and replenishing the stores
Prevention is by nutrirional education and
supplementation in diets
7/10/2023
50
52. REFERENCES
New concepts in iron deficiency anaemia.
British journal of General practice 2017
Camaschella C. New insights into iron
deficiency and iron deficiency anaemia.
Blood Rev.2017
Williams Hematology 9th Edition
Postgraduate Haematology 7 Edition A. V.
Hoffbrand
7/10/2023
52
53. QUIZ 5 minutes
One of your senior colleagues that took
part in the just concluded examination
in laboratory medicine and
pharmacology was excited by the
outcome and invited you for an outing
where you ate bread , suya and drank a
cup of tea. What is wrong with such a
combination? What is the
pathophysiology of the attendant
problem ?
7/10/2023
53